Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Michalovce – page 4

240 clinical trials in Michalovce, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Michalovce at a glance
240
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

240 trials in Michalovce

Open in trial search

Efficacy and safety of ABP 938 compared with aflibercept in participants with neovascular age‑related macular degeneration

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.

Efficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Golimumab
  • Sponsor:Janssen Cilag International

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Phase 3 Study of Enpatoran in Patients with Active Cutaneous Lupus Erythematosus (with or without Systemic Disease)

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Enpatoran hemihydrate
  • Sponsor:Merck Healthcare KGaA

A Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyebiotech Limited

Asthma

Recruiting

Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

Registered drug
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Indacaterol Acetate
  • Sponsor:Novartis Pharma AG

Long‑Term Safety and Tolerability of Oral Fesoterodine in Adults with Hallucinations and Delusions Due to Alzheimer’s Disease Psychosis

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Betovumeline
  • Sponsor:Maplight Therapeutics Inc.

Crohn's disease

Recruiting

A Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Asthma

Recruiting

Efficacy and safety of GB-0895 as adjunctive therapy in adults and adolescents with severe uncontrolled asthma (randomized, placebo‑controlled)

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:GB-0895
  • Sponsor:Generate Biomedicines Inc.

Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Dyslipidaemia

Recruiting

Comparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
  • Sponsor:A. Menarini International Licensing S.A.

Asthma

Recruiting

A study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:KT-621
  • Sponsor:Kymera Therapeutics Inc.

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Michalovce

What the registry says about research in the country

01 Breast Cancer Research

Comprehensive studies focusing on hormone receptor-positive (HR+) and HER2-negative breast cancer, evaluating novel therapeutic combinations and treatment approaches for advanced and metastatic cases.

  • Advanced treatment combinations
  • Metastatic disease management
  • Hormone therapy resistance

Multiple trials investigating innovative therapeutic options for patients who have progressed after initial treatments.

02 Respiratory Medicine

Research examining new treatments for moderate to severe asthma, including studies of innovative inhaler formulations and delivery systems to improve patient outcomes.

  • Asthma management
  • Respiratory drug delivery
  • Bronchial response studies

Evaluation of advanced inhaler technologies and their safety profiles in controlled asthma patients.

03 Infectious Diseases

Investigations into treatment options for community-acquired pneumonia (CAP) and COVID-19, testing novel therapeutic approaches in combination with standard care protocols.

  • Pneumonia treatment
  • COVID-19 interventions
  • Immunological responses

Studies focusing on adjunctive treatments to improve outcomes in hospitalized patients.

04 Oncology & Immunotherapy

Advanced research in non-small cell lung cancer (NSCLC) treatment, exploring innovative immunotherapy combinations and targeted therapies for various cancer stages.

  • Post-surgical treatment
  • Immunotherapy combinations
  • Cancer progression prevention

Evaluation of novel therapeutic approaches in cancer treatment following standard interventions.

05 Hepatology

Innovative research examining treatments for non-alcoholic steatohepatitis (NASH), focusing on improving liver histology and reducing liver-related clinical events.

  • Liver disease management
  • Fibrosis treatment
  • Disease progression prevention

Clinical evaluation of therapeutic interventions for various stages of liver fibrosis.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.